Current Prophylactic Medications for Migraine and Their Potential Mechanisms of Action

被引:75
作者
Sprenger, Till [1 ]
Viana, M. [2 ]
Tassorelli, C. [2 ,3 ]
机构
[1] DKD Helios Klin Wiesbaden, Dept Neurol, Aukammallee 33, D-65191 Wiesbaden, Germany
[2] IRCCS, Mondino Fdn, Headache Sci Ctr, I-27100 Pavia, Italy
[3] Univ Pavia, Dept Brain & Behav Sci, I-27100 Pavia, Italy
关键词
Migraine prevention; Mechanism of actions; Cortical spreading depression; beta blockers; Antiepileptic drugs; Antidepressants; Botulinumtoxin; TOXIN TYPE-A; CORTICAL SPREADING DEPRESSION; CHRONIC DAILY HEADACHE; PLACEBO-CONTROLLED PHASE; TENSION-TYPE HEADACHE; HIGH-DOSE RIBOFLAVIN; FACTOR-KAPPA-B; BOTULINUM-TOXIN; DOUBLE-BLIND; BETA-BLOCKERS;
D O I
10.1007/s13311-018-0621-8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A relatively high number of different medications is currently used for migraine prevention in clinical practice. Although these compounds were initially developed for other indications and differ in their mechanisms of action, some general themes can be identified from the mechanisms at play. Efficacious preventive drugs seem to either suppress excitatory nervous signaling via sodium and/or calcium receptors, facilitate GABAergic inhibition, reduce neuronal sensitization, block cortical spreading depression and/or reduce circulating levels of CGRP. We here review such mechanisms for the different compounds.
引用
收藏
页码:313 / 323
页数:11
相关论文
共 144 条
[51]   A COMPARISON OF THE EFFECTS OF AN EXTRACT OF FEVERFEW AND PARTHENOLIDE, A COMPONENT OF FEVERFEW, ON HUMAN PLATELET ACTIVITY INVITRO [J].
GROENEWEGEN, WA ;
HEPTINSTALL, S .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1990, 42 (08) :553-557
[52]  
Grossman W, 2001, Altern Med Rev, V6, P303
[53]   Magnesium therapy for migraine: Do we need more trials or more reflection? [J].
Gupta, VK .
HEADACHE, 2004, 44 (05) :445-446
[54]   INHIBITION BY TETANUS AND BOTULINUM-A TOXIN OF THE RELEASE OF [H-3]NORADRENALINE AND [H-3]GABA FROM RAT-BRAIN HOMOGENATE [J].
HABERMANN, E .
EXPERIENTIA, 1988, 44 (03) :224-226
[55]  
HANBAUER I, 1975, J PHARMACOL EXP THER, V193, P95
[56]   INTENSITY DEPENDENCE OF AUDITORY EVOKED-POTENTIALS AS AN INDICATOR OF CENTRAL SEROTONERGIC NEUROTRANSMISSION - A NEW HYPOTHESIS [J].
HEGERL, U ;
JUCKEL, G .
BIOLOGICAL PSYCHIATRY, 1993, 33 (03) :173-187
[57]  
Hieble J P, 2000, Pharm Acta Helv, V74, P163, DOI 10.1016/S0031-6865(99)00030-8
[58]   Prophylactic Drugs and Cytokine and Leptin Levels in Children With Migraine [J].
Hirfanoglu, Tugba ;
Serdaroglu, Ayse ;
Gulbahar, Ozlem ;
Cansu, Ali .
PEDIATRIC NEUROLOGY, 2009, 41 (04) :281-287
[59]   Oxcarbazepine does not suppress cortical spreading depression [J].
Hoffmann, Ulrike ;
Dilekoez, Ergin ;
Kudo, Chiho ;
Ayata, Cenk .
CEPHALALGIA, 2011, 31 (05) :537-542
[60]   Role of angiotensin II type 1 receptor in the leucocytes and endothelial cells of brain microvessels in the pathogenesis of hypertensive cerebral injury [J].
Ito, H ;
Takemori, K ;
Suzuki, T .
JOURNAL OF HYPERTENSION, 2001, 19 (03) :591-597